Switch to:
Also traded in: Argentina, Brazil, Chile, Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt N/A
ABT's Cash to Debt is ranked higher than
76% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. ABT: N/A )
Ranked among companies with meaningful Cash to Debt only.
ABT' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.31 Max: 1.23
Current: N/A
0.05
1.23
Equity to Asset 0.51
ABT's Equity to Asset is ranked lower than
69% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. ABT: 0.51 )
Ranked among companies with meaningful Equity to Asset only.
ABT' s Equity to Asset Range Over the Past 10 Years
Min: 0.37  Med: 0.44 Max: 0.59
Current: 0.51
0.37
0.59
Interest Coverage 18.42
ABT's Interest Coverage is ranked lower than
63% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 53.44 vs. ABT: 18.42 )
Ranked among companies with meaningful Interest Coverage only.
ABT' s Interest Coverage Range Over the Past 10 Years
Min: 4.91  Med: 11.51 Max: 17.59
Current: 18.42
4.91
17.59
F-Score: 7
Z-Score: 3.73
M-Score: -2.46
WACC vs ROIC
11.79%
72.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 13.64
ABT's Operating margin (%) is ranked higher than
81% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. ABT: 13.64 )
Ranked among companies with meaningful Operating margin (%) only.
ABT' s Operating margin (%) Range Over the Past 10 Years
Min: 9.09  Med: 16.06 Max: 20.28
Current: 13.64
9.09
20.28
Net-margin (%) 12.00
ABT's Net-margin (%) is ranked higher than
81% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. ABT: 12.00 )
Ranked among companies with meaningful Net-margin (%) only.
ABT' s Net-margin (%) Range Over the Past 10 Years
Min: 7.64  Med: 13.54 Max: 21.68
Current: 12
7.64
21.68
ROE (%) 11.25
ABT's ROE (%) is ranked higher than
73% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. ABT: 11.25 )
Ranked among companies with meaningful ROE (%) only.
ABT' s ROE (%) Range Over the Past 10 Years
Min: 9.78  Med: 20.51 Max: 28.49
Current: 11.25
9.78
28.49
ROA (%) 5.79
ABT's ROA (%) is ranked higher than
69% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: -0.71 vs. ABT: 5.79 )
Ranked among companies with meaningful ROA (%) only.
ABT' s ROA (%) Range Over the Past 10 Years
Min: 4.68  Med: 8.77 Max: 12.12
Current: 5.79
4.68
12.12
ROC (Joel Greenblatt) (%) 35.40
ABT's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. ABT: 35.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ABT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 22.28  Med: 44.88 Max: 65.75
Current: 35.4
22.28
65.75
Revenue Growth (3Y)(%) -18.50
ABT's Revenue Growth (3Y)(%) is ranked lower than
83% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. ABT: -18.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ABT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.8  Med: 8.30 Max: 12.6
Current: -18.5
-18.8
12.6
EBITDA Growth (3Y)(%) -19.20
ABT's EBITDA Growth (3Y)(%) is ranked lower than
81% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. ABT: -19.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ABT' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -21.2  Med: 4.90 Max: 31.6
Current: -19.2
-21.2
31.6
EPS Growth (3Y)(%) 125.50
ABT's EPS Growth (3Y)(%) is ranked higher than
95% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. ABT: 125.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ABT' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -65.6  Med: 8.70 Max: 125.5
Current: 125.5
-65.6
125.5
» ABT's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-22)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

ABT Guru Trades in Q2 2015

Ray Dalio 28,457 sh (New)
Joel Greenblatt 1,043,293 sh (+2409.54%)
Paul Tudor Jones 13,700 sh (+47.31%)
First Eagle Investment 5,916,570 sh (+15.05%)
Ken Fisher 14,994 sh (+14.50%)
John Buckingham 91,559 sh (+0.72%)
Vanguard Health Care Fund 7,591,400 sh (unchged)
Tom Russo 85,400 sh (unchged)
Westport Asset Management 200,000 sh (unchged)
George Soros 602,181 sh (unchged)
Louis Moore Bacon 300,000 sh (unchged)
Robert Bruce 230,915 sh (unchged)
Murray Stahl 18,603 sh (unchged)
Jim Simons Sold Out
Jeff Auxier 77,821 sh (-0.06%)
PRIMECAP Management 17,737,310 sh (-0.16%)
Richard Pzena 6,340,115 sh (-0.53%)
Diamond Hill Capital 8,062,685 sh (-0.55%)
Dodge & Cox 31,268 sh (-2.49%)
Mairs and Power 341,838 sh (-3.36%)
Mario Gabelli 61,032 sh (-6.52%)
Pioneer Investments 1,861,927 sh (-6.71%)
Robert Olstein 159,000 sh (-11.17%)
Jeremy Grantham 9,499,219 sh (-11.45%)
» More
Q3 2015

ABT Guru Trades in Q3 2015

John Hussman 3,000 sh (New)
Jim Simons 1,348,400 sh (New)
Paul Tudor Jones 59,714 sh (+335.87%)
Ray Dalio 82,457 sh (+189.76%)
Joel Greenblatt 1,455,289 sh (+39.49%)
George Soros 731,481 sh (+21.47%)
Murray Stahl 21,503 sh (+15.59%)
First Eagle Investment 6,825,289 sh (+15.36%)
Robert Olstein 176,000 sh (+10.69%)
Diamond Hill Capital 8,385,413 sh (+4.00%)
Ken Fisher 15,254 sh (+1.73%)
Jeff Auxier 78,922 sh (+1.41%)
John Buckingham 91,905 sh (+0.38%)
Westport Asset Management 200,000 sh (unchged)
David Carlson 600,000 sh (unchged)
Robert Bruce 230,915 sh (unchged)
Tom Russo 85,400 sh (unchged)
Dodge & Cox 30,268 sh (-3.20%)
PRIMECAP Management 16,677,764 sh (-5.97%)
Mairs and Power 319,343 sh (-6.58%)
Vanguard Health Care Fund 6,938,700 sh (-8.60%)
Richard Pzena 5,188,346 sh (-18.17%)
Jeremy Grantham 6,469,218 sh (-31.90%)
Pioneer Investments 1,213,173 sh (-34.84%)
Mario Gabelli 17,625 sh (-71.12%)
» More
Q4 2015

ABT Guru Trades in Q4 2015

Robert Olstein 201,000 sh (+14.20%)
Ken Fisher 17,286 sh (+13.32%)
Murray Stahl 22,503 sh (+4.65%)
Diamond Hill Capital 8,621,765 sh (+2.82%)
Mario Gabelli 17,625 sh (unchged)
Jeff Auxier 78,922 sh (unchged)
Tom Russo 85,400 sh (unchged)
Robert Bruce 230,915 sh (unchged)
David Carlson 600,000 sh (unchged)
Dodge & Cox 30,268 sh (unchged)
Westport Asset Management 200,000 sh (unchged)
Spiros Segalas 9,871,440 sh (unchged)
Jim Simons Sold Out
John Hussman Sold Out
Pioneer Investments 1,212,972 sh (-0.02%)
Mairs and Power 318,918 sh (-0.13%)
PRIMECAP Management 16,643,039 sh (-0.21%)
John Buckingham 91,506 sh (-0.43%)
First Eagle Investment 6,671,344 sh (-2.26%)
Richard Pzena 4,861,129 sh (-6.31%)
George Soros 664,181 sh (-9.20%)
Jeremy Grantham 5,653,313 sh (-12.61%)
Vanguard Health Care Fund 6,027,260 sh (-13.14%)
Ray Dalio 38,857 sh (-52.88%)
Paul Tudor Jones 13,100 sh (-78.06%)
Joel Greenblatt 98,838 sh (-93.21%)
» More
Q1 2016

ABT Guru Trades in Q1 2016

Murray Stahl 22,778 sh (+1.22%)
Ken Fisher 15,413 sh (-10.84%)
Spiros Segalas 9,668,976 sh (-2.05%)
» More
» Details

Insider Trades

Latest Guru Trades with ABT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK